Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003163785 | SCV003906808 | uncertain significance | Inborn genetic diseases | 2023-02-23 | criteria provided, single submitter | clinical testing | The c.646A>G (p.I216V) alteration is located in exon 8 (coding exon 8) of the SEC63 gene. This alteration results from a A to G substitution at nucleotide position 646, causing the isoleucine (I) at amino acid position 216 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Gastroenterology and Hepatology, |
RCV001844950 | SCV001876883 | likely pathogenic | Autosomal dominant polycystic liver disease | 2021-09-01 | no assertion criteria provided | research |